80-lead ECG device detects more heart attacks, says study
This article was originally published in Clinica
Meridian Medical Technologies, which recently gained US approval for its 80-lead ECG system, says it now has new clinical data to further support the use of the device over traditional 12-lead ECG systems.
You may also be interested in...
Oncology Center of Excellence is reviewing a research report on fluorouracil, and will next look to update cisplatin's label, but eventually must convince the reference product sponsor to submit the changes.
US FDA’s ‘Project Renewal’ requires lots of work and flexibility, Oncology Center of Excellence acknowledges. Side-benefit may be getting outside physicians to appreciate the value of drug labeling.
The pharmaceutical industry would lose bid to eliminate PUPSIT but win relaxed WFI in proposed EU GMP Annex I revision.